Buscar
Compass Pathways PLC
CMPSAñadir a la lista de seguimiento
10.990USD
+0.140+1.29%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
680.11MCap. mercado
PérdidaP/E TTM
Más Datos de Compass Pathways PLC Compañía
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Información de Compass Pathways PLC
Símbolo de cotizaciónCMPS
Nombre de la empresaCompass Pathways PLC
Fecha de salida a bolsaSep 18, 2020
Director ejecutivoNath (Kabir)
Número de empleados166
Tipo de seguridadDepository Receipt
Fin del año fiscalSep 18
Dirección3Rd Floor, 1 Ashley Road
CiudadALTRINCHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited Kingdom
Código postalWA14 2DT
Teléfono17166766461
Sitio Webhttps://compasspathways.com/
Símbolo de cotizaciónCMPS
Fecha de salida a bolsaSep 18, 2020
Director ejecutivoNath (Kabir)
Ejecutivos de Compass Pathways PLC
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Robert McQuade, Ph.D.
Dr. Robert McQuade, Ph.D.
Independent Director
Independent Director
1.59M
--
Mr. Thomas Lonngren
Mr. Thomas Lonngren
Independent Director
Independent Director
89.05K
--
Mr. Kabir Nath
Mr. Kabir Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
58.19K
-228.13%
Ms. Teri Loxam
Ms. Teri Loxam
Chief Financial Officer
Chief Financial Officer
26.89K
-197.34%
Mr. David Norton
Mr. David Norton
Independent Director
Independent Director
20.36K
--
Dr. Annalisa M. Jenkins
Dr. Annalisa M. Jenkins
Independent Director
Independent Director
19.48K
--
Dr. Guy Goodwin
Dr. Guy Goodwin
Chief Medical Officer
Chief Medical Officer
1.99K
--
Dr. Wayne Joseph Riley, M.D.
Dr. Wayne Joseph Riley, M.D.
Independent Director
Independent Director
--
--
Ms. Daphne Karydas
Ms. Daphne Karydas
Independent Director
Independent Director
--
--
Mr. Gino Santini
Mr. Gino Santini
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Robert McQuade, Ph.D.
Dr. Robert McQuade, Ph.D.
Independent Director
Independent Director
1.59M
--
Mr. Thomas Lonngren
Mr. Thomas Lonngren
Independent Director
Independent Director
89.05K
--
Mr. Kabir Nath
Mr. Kabir Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
58.19K
-228.13%
Ms. Teri Loxam
Ms. Teri Loxam
Chief Financial Officer
Chief Financial Officer
26.89K
-197.34%
Mr. David Norton
Mr. David Norton
Independent Director
Independent Director
20.36K
--
Dr. Annalisa M. Jenkins
Dr. Annalisa M. Jenkins
Independent Director
Independent Director
19.48K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Compass Pathways PLC?
Los cinco principales accionistas de Compass Pathways PLC son: Dr. Robert McQuade, Ph.D.
¿Cuántas instituciones poseen acciones de Compass Pathways PLC (CMPS)?
A fecha de 2026Q1, 313 instituciones poseen acciones de Compass Pathways PLC, con un valor de mercado combinado de aproximadamente 60.19M, lo que representa el 44.61% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -22728311.00.